CVS Health Corporation stock surges 4.8%, but downtrend isn’t broken yet

CVS — daily chart with candlesticks, EMA20/EMA50 and volume.

Key takeaways

• CVS Health Corporation stock surged 4.8% on September 25, closing at $89.13 and reclaiming the 200-day EMA at $88.91.
• The daily trend remains bearish, with price still below the 20-day EMA at $91.42 and the 50-day EMA at $94.58.
• Daily RSI14 at 40.05 and a negative MACD histogram at -0.55 confirm the broader downtrend is intact.
• Hourly momentum has flipped bullish with a MACD crossover, though RSI14 at 69.03 now nears overbought territory.
• Key levels to watch: R1 resistance at $90.75 and S1 support at $86.10, framing the immediate decision zone.

CVS Health Corporation stock surged 4.8% on September 25, closing at $89.13 after eight consecutive losing sessions. The rally reclaimed the 200-day EMA and the daily pivot. Yet the broader technical picture remains unresolved—a violent bounce inside a still-bearish trend structure.

Daily Chart: A Bounce Inside a Downtrend

The daily chart shows CVS Health Corporation stock bouncing sharply within a broader downtrend that remains structurally intact. CVS opened at $85.35 and closed at $89.13, with a session high of $89.35 and low of $84.70. The stock reversed off its lower Bollinger Band at $84.63, near the day’s low. Meanwhile, the upper band sits far away at $100.64 and the midline at $92.64, highlighting the wide volatility envelope.

EMA Resistance and Momentum Readings

Despite the bounce, price remains below both the 20-day EMA at $91.42 and the 50-day EMA at $94.58. This layered EMA structure—price under both short and medium-term averages—signals a downtrend that has not been broken, only interrupted. The daily RSI14 at 40.05 confirms this reading. It has lifted from oversold territory but stays below the neutral 50 line. Momentum has improved without flipping bullish.

MACD, Volatility, and Pivot Levels

The daily MACD adds another layer of caution. The MACD line sits at -2.68, below the signal line at -2.13, with a histogram of -0.55. Therefore, the broader momentum indicator remains bearish despite the sharp rally. The ATR14 reading of 2.4 also confirms elevated volatility, consistent with a stock gapping through multiple levels in a single session.

On the pivot framework, price closed above the pivot point at $87.73. It is now testing the area toward R1 at $90.75. S1 at $86.10 serves as the first line of defense if the bounce fails.

Hourly Momentum Confirms the Rebound, For Now

The hourly chart shows genuine bullish momentum has taken hold, though the rally is now approaching overbought levels. Price closed at $89.13, above both the 20-hour EMA ($87.14) and the 50-hour EMA ($88.22). However, it remains below the 200-hour EMA at $93.04. This mixed alignment shows the rebound has real short-term traction, even if the larger hourly trend has not fully turned.

RSI Nears Overbought, MACD Turns Bullish

Hourly RSI14 stands at 69.03, close to overbought territory. This reflects the strength of the move but also signals the rally is getting stretched. The hourly MACD is more encouraging for bulls. The line at 0.24 is now above the signal at -0.34, with a positive histogram of 0.59. This hourly MACD crossover confirms bullish momentum on the hourly chart, in contrast with the still-negative daily MACD. The conflict is explicit: the daily trend remains bearish while hourly momentum has flipped bullish.

Bollinger Bands Frame a Tight Decision Zone

Price is pressing against the upper hourly Bollinger Band at $89.26, with the midline at $86.35. Sitting this close to the upper band after a fast move suggests limited room for immediate follow-through without consolidation. Moreover, the hourly pivot point at $89.13 matches the closing price almost exactly. R1 at $89.35 sits just overhead and S1 at $88.91 just below, framing a tight decision zone.

15-Minute Chart: Signs of Intraday Exhaustion

The 15-minute chart signals fading upside momentum, suggesting the rally is due for a pause or pullback before any further advance. The 15-minute timeframe is useful only for execution timing, and here the signals point to fatigue.

RSI14 has climbed to 76.29, deep into overbought territory. At the same time, the MACD histogram has compressed to just 0.03. The MACD line at 0.77 remains above the signal at 0.74, but upside momentum on this micro timeframe is fading even as price holds near its highs. Price is also hugging the upper Bollinger Band at $89.37, with the midline at $88.30.

The 15-minute pivot at $89.11 and R1 at $89.31 show the stock is boxed into a narrow range right at resistance. For short-term positioning, this suggests waiting for a pullback toward the 15-minute EMA20 at $88.15 or the pivot zone, rather than chasing the move at current levels.

The Bullish Case for CVS Health Corporation Stock

The bullish thesis rests on the idea that this reversal is more than a one-day squeeze—and that the eight-session slide was overdone. If price can hold above the daily EMA200 at $88.91 and the daily pivot at $87..73,, the next real test becomes R1 at $90.75.. A clean break there would open the path toward the Bollinger midline at $92.64.. Ultimately, that would bring the 50-day EMA at $94.58 into play.

News flow offers some support for this view. A Seeking Alpha piece published the same day argued that CVS Health remains fairly attractive, rated a soft Buy on improved profitability and relative valuation. It acknowledged potential health cost pressures but maintained a constructive stance. Separately, a Yahoo Finance article noted that the average brokerage recommendation points toward CVS being a good investment. However, it also flagged that consensus ratings can run overly optimistic. Combined with the bullish hourly MACD crossover, there is a credible case that the Omnicare wind-down plan sell-off was overdone and the stock is now attracting fresh investor attention.

The Bearish Case

The bearish case is built directly on the daily chart’s unresolved structure, with price still trapped below key moving averages. The daily MACD histogram stays negative at -0.55., meaning the broader momentum indicator has not confirmed a trend change. If CVS fails to hold above the EMA200 and pivot zone, a slide toward S1 at $86.10 becomes likely. A break below that could test the lower Bollinger Band near $84.63.. Such a move would confirm the bounce was merely a relief rally inside an intact downtrend.

The catalyst behind the prior eight-day decline—the approved Omnicare wind-down plan—remains a fundamental overhang. The technical bounce has not erased it. Additionally, extreme overbought readings increase the risk of a short-term pullback. The hourly RSI stands at 69.03 and the 15-minute RSI at 76.29.. Should momentum stall at current resistance and roll over, that would invalidate the immediate bullish thesis. Focus would shift back toward defending the daily pivot and EMA200.

Positioning and Volatility Outlook

Overall, CVS Health Corporation stock sits at a genuine inflection point where timeframes disagree, making the disagreement itself the key takeaway. The daily trend is neutral-to-bearish. Hourly momentum has turned constructive. Yet the 15-minute chart flashes overbought exhaustion. Elevated ATR readings on both daily (2.4) and hourly (0.78) scales confirm that volatility is running high. This raises the stakes for whichever direction resolves first.

In this environment, chasing the move at current levels carries clear risk given the overbought intraday readings. At the same time, dismissing the rebound outright ignores the improved hourly momentum and constructive analyst commentary. Until price decisively clears R1 at $90.75 or breaks below S1 at $86.10,, the fair characterization remains elevated uncertainty. This is not yet a confirmed trend shift.

FAQ

What drove CVS Health Corporation stock’s sharp 4.8% rally on September 25?

The rally followed eight consecutive losing sessions triggered by the approved Omnicare wind-down plan. The sharp bounce was partly technical, reversing off the lower daily Bollinger Band at $84.63. Positive analyst commentary from Seeking Alpha and Yahoo Finance, highlighting improved profitability and relative valuation, also supported the move.

Is CVS Health Corporation stock still in a downtrend?

Yes, from a daily chart perspective. Despite the bounce, price remains below the 20-day EMA ($91.42) and the 50-day EMA ($94.58). The daily MACD histogram remains negative at -0.55, and RSI14 at 40.05 is still below the neutral 50 line.

What are the key levels to watch for CVS Health Corporation stock?

The key resistance level is R1 at $90.75. A break above that opens the path to the Bollinger midline at $92.64 and the 50-day EMA at $94.58. On the downside, S1 at $86.10 is the first support, followed by the lower Bollinger Band near $84.63.

Does the hourly chart support a continued rally in CVS stock?

The hourly chart shows a bullish MACD crossover, confirming short-term momentum has flipped positive. However, RSI14 at 69.03 is approaching overbought territory, suggesting the rally may need consolidation before further gains.

Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.